Clinical Trials Directory

Trials / Completed

CompletedNCT03842514

Food Additives - Do Processed Diets Impact on Gut and Metabolic Health

Investigation of the Effects of Dietary Lecithin on Intestinal Permeability, Bacterial Translocation, Microbiota and Glucose Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This dietary intervention study will assess the effect in healthy human volunteers of an E number which is a food additive and commonly used and consumed emulsifier, on gut function, gut inflammation and glucose metabolism. We will be using a powdered soy lecithin product in the food to compare a diet with and without this ingredient.

Detailed description

A dietary intervention study to investigate the effect, in healthy human volunteers, of dietary lecithin (soy lecithin), a commonly used/consumed emulsifier, on markers of gut function particularly bacterial translocation (assessed by measure of venous blood bacterial DNA, circulating lipopolysaccharide \[LPS\] binding protein and soluble CD14), gut inflammation (assessed by measurement of faecal calprotectin), gut microbiota activity/composition (faecal short-chain fatty acid \[SCFA\] profile and bacterial diversity \[16S ribosomal RNA genes\]) and glucose metabolism (measured by oral glucose tolerance test \[OGGT\], plasma fasted lipids and insulin).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSoya lecithinThe lecithin supplement will be soya lecithin granules given as 7.5 g twice daily, incorporated into juices

Timeline

Start date
2019-05-01
Primary completion
2020-03-04
Completion
2020-03-04
First posted
2019-02-15
Last updated
2020-03-06

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03842514. Inclusion in this directory is not an endorsement.